True, CABG is superior to ICP in diabetic patients with multivessel disease but ICP resolves better when CABG cannot. @jaccjournals https://t.co/NghZr9G1H8 #drerwintellez #radialfirst
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease. https://t.co/5BXn4doL9F
For the study: https://t.co/gjvP7qdp6u
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @Ontivero_BJ: @CirujaBarbosa
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
@CirujaBarbosa
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
RT @edurontoFF: .La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multi…
.La CRM reduce 39% la mortalidad y 99% el MACE con respecto a la ATC en pacientes diabeticos con enfermedad coronaria multivaso, en un seguimiento a 5,5-11,5 años. A mayor tiempo de seguimiento mas bebeficio con la CRM. @SAC_54 @SIAC_cardio @CONAREC_ORG ht
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease | JACC: Journal of the American College of Cardiology https://t.co/mfhcsc6rV8
RT @sghcsscc: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Diseas…
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease https://t.co/PnLSYOfx2s
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
RT @sghcsscc: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Diseas…
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease https://t.co/UQjQLEwK9C
RT @rafasadaba: CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease. https://t.co/5BXn4doL9F
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
@sunlouise1 and @OttAnesthesia influencing the course of surgical care in cardiac disease
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @PMunkCardiacCtr: In patients with multivessel coronary artery disease and diabetes, bypass surgery may be associated with improved long…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
26% had repeat revascularization following PCI
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @rafasadaba: CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
The message from this Real Life Observational study is: For patients who can have CABG, i.e for whom CABG is an option, CABG results in better outcomes in the long-term than Angioplasty.
We are learning a lot in cad Cabg is 👌 superior to pci in multilevel disease in diabetes
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @rafasadaba: CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @DrDerekConnolly: Registry data from Canada 🇨🇦 “In patients with multivessel CAD and diabetes, CABG was associated with improved long-…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @rafasadaba: CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
RT @PMunkCardiacCtr: In patients with multivessel coronary artery disease and diabetes, bypass surgery may be associated with improved long…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @drbarryrubin: In #CAD patients with #diabetes, bypass surgery ⬆️ long-term survival & ⬇️composite of ❤️attack, repeat revascularization…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @alxbenevides: Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserte…
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @PMunkCardiacCtr: In patients with multivessel coronary artery disease and diabetes, bypass surgery may be associated with improved long…
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease | JACC: Journal of the American College of Cardiology https://t.co/CugH8HmoRp
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @PMunkCardiacCtr: In patients with multivessel coronary artery disease and diabetes, bypass surgery may be associated with improved long…
RT @PMunkCardiacCtr: In patients with multivessel coronary artery disease and diabetes, bypass surgery may be associated with improved long…
In patients with multivessel coronary artery disease and diabetes, bypass surgery may be associated with improved long-term survival and decreased instances of heart attacks & strokes when compared to PCI. New research from members of the PMCC team →
RT @Susumu_Manabe: カナダオンタリオ州のデータベースを使用した、糖尿病多枝病変の患者に対するカテーテル(PCI)と手術(CABG)の比較試験。対象はPCIが4,519例、CABGが9,716例。遠隔期死亡は1.39倍、主要心事故は1.99倍PCIが高い htt…
RT @DrDerekConnolly: Registry data from Canada 🇨🇦 “In patients with multivessel CAD and diabetes, CABG was associated with improved long-…
RT @rafasadaba: CABG appears to offer survival advantage over PCI in patients with diabetes and multivessel CAD 👇 https://t.co/CUhXSvLcDA
RT @BobbyYanagawa: Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary D…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @NimeshDesaiMD: Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LA…
RT @alxbenevides: Long-Term Survival After #Surgical Revascularization vs #PCI in Pts W/#Diabetes & #Multivessel Coronary Disease reasserte…